VACSERA collaborating with Bilthoven Biologicals
A significant milestone for Egypt’s self-sufficiency on polio vaccines was reached on October 21st with the signing of the tech transfer agreement between VACSERA and Bilthoven Biologicals. The signing took place on the sidelines of Egypt’s second edition of the Global Congress on Population, Health and Human Development 2024, held under the auspices of President Abdel Fattah Al-Sisi, with the slogan “Human Development: For a Sustainable Future.”
Egypt’s Deputy Prime Minister and Minister of Health and Population, Khaled Abdel Ghaffar, witnessed the signing of a cooperation agreement between the Holding Company for Biological Products and Vaccines (VACSERA) and the Dutch company Bilthoven Biologicals (BBio) to transfer the technology of manufacturing the injectable polio vaccine.
Basil Babychan, Commercial director at BBio: “What we are doing is to bring the technology to Egypt, where the product is filled, finished and supplied in the Egyptian market through VACSERA”. Jurgen Kwik, CEO at BBio adds: “This development aligns with BBio’s mission to be at the forefront of the fight against polio and achieve polio eradication. It’s a great pleasure to bring this announcement today, on World Polio Day 2024”.
Hossam Abdel Ghaffar, spokesperson for the Ministry of Health and Population of Egypt, explained that Bilthoven Biologicals is one of the leading Dutch companies in the field of transferring vaccine manufacturing technology, and this is the first time the company has transferred vaccine manufacturing technology outside Europe, in addition to the company providing all means of support in the steps of qualifying the vaccine to comply with good manufacturing conditions to ensure quality.
Sherif Al-Feel, Managing Director of the Holding Company for Biological Products and Vaccines (VACSERA), said that the injectable polio vaccine is one of the vaccines used to keep Egypt free of polio, adding that signing the cooperation agreement is a step towards localizing the vaccine industry and achieving self-sufficiency in the injectable polio vaccine, with the possibility of exporting the product to African countries. VACSERA is the state led producer of sera and vaccines in Egypt.
Betweter Festival during Utrecht Science Week 2026: your idea for an experiment is welcome!
Utrecht Science Week kicks off this year on Friday, September 25th. The Betweter Festival at Tivoli Vredenburg is the ever-popular opening night event. This year marks the tenth edition of the Betweter Festival. This art and science festival, where visitors immerse themselves in a unique mix of talks, music, film, interactive installations, and live research, is inviting participants to submit ideas for experiments during the festival.
Princess Máxima Center to expand with innovation wing thanks to partnership between the Foundation and Rabobank
The Princess Máxima Center for pediatric oncology will be able to start expanding the center later this year with a five thousand square meter innovation wing. This has been made possible by a multi-year strategic partnership between the Princess Máxima Center Foundation and Rabobank. The new innovation wing will provide space for pioneering research, innovation in care, and collaboration programs. This expansion supports the development of better and more effective treatments for children with cancer.
New Year’s promotion: all-in sports with a generous discount at Sportcentrum Olympos
Employees of Utrecht University, Utrecht University of Applied Sciences (HU), UMCU, Hubrecht Institute and Westerdijk Institute can temporarily enjoy an extra 20% discount on all-in sports at Olympos!
Wennink plan: Life Sciences and biotechnology are important growth drivers for the earning capacity of the Netherlands
The Dutch Life Sciences and biotechnology sector can make a much larger contribution to the Netherlands’ economic strength. This is shown in a new growth strategy presented today as part of Peter Wennink’s advisory report. The report also highlights Utrecht Science Park as one of the key innovation locations and sources of progress and growth.